NCT04368546View on ClinicalTrials.gov

Sunitinib Treatment on Tissue Sodium Accumulation (TSS2)

CompletedOBSERVATIONAL

Enrollment

6

Participants

Timeline

Start Date

November 1, 2015

Primary Completion Date

February 1, 2019

Study Completion Date

March 1, 2020

Conditions

Renal Cell Cancer MetastaticHypertensionSodium Imbalance

Interventions

DRUG

Sunitinib

Trial Locations (1)

13125

Experimental and Clinical Research Center, Clinical Research Unit, Berlin

Sponsors

Collaborators (1)

German Heart Institute

All Listed Sponsors

collaborator

German Heart Institute

OTHER

lead

Charite University, Berlin, Germany

OTHER

NCT04368546 - Sunitinib Treatment on Tissue Sodium Accumulation (TSS2) | Biotech Hunter | Biotech Hunter